“flagship-ventures” Archives

in
Entry Author Date Location
Eleven Bio Buys Viventia, Rebrands as Cancer Drug Developer 09/21/16 Boston
Seeking to Join Editas, Intellia, CRISPR Tx Makes Long Awaited IPO Push 09/12/16 Boston
Filing: Moderna Blowing Past Record $450M Round With New $600M Raise 08/29/16 Boston
3D Printing Startup NVBots Nabs Cash & New CEO, Moves Into Metal 08/18/16 Boston
In a Microbiome Setback, Seres Drug Fails in Phase 2, Shares Crushed 07/29/16 Boston
With $40M Bid, Pfizer Set to Buy, And Close, Bankrupt Bind Tx 07/27/16 Boston
Indigo’s Microbial Tech for Crops Lands $100M to Fight Plant Stresses 07/21/16 Boston
With Bugs As Drugs, Evelo CEO Plans Immune, Cancer Trials in 2017 07/12/16 Boston
Pfizer Might Buy Bind Therapeutics From Bankruptcy for $20M 07/06/16 Boston
Syros Cuts Price But Bags $50M in IPO to Fuel Cancer Drug Trials 06/29/16 Boston
Alexandria Sets up Incubator, $25M Seed Fund For NY Bio Startups 06/08/16 New York
Pronutria Rebrands as Axcella Health, Forms “Nutrition” Subsidiary 06/07/16 Boston
Syros Files For IPO to Push “Gene Control” Drugs Through First Trials 06/06/16 Boston
Retooled Selecta Bio Takes Crossover Cash to IPO Queue 05/24/16 Boston
CarGurus CEO on Profitable Tech Startups, and Why Uber Is Road Kill 05/16/16 Boston
Amid Leadership Changes, NY Biotech Braces For its “Pivotal Moment” 05/12/16 New York
Pressured by a Lender, Bind Files for Bankruptcy 05/02/16 Boston
Bind Therapeutics Sheds Employees, Considers New Capital or Deals 04/06/16 Boston
“Raw Potential” And Three Other Takeaways from NY’s Life Science Disruptors 03/30/16 New York
Pronutria, Eyeing Clinical Push, Gets $42.5M From Nestle Health 02/23/16 Boston
From Funding to “Failure,” Boston Tech’s Roller Coaster Week 02/19/16 Boston
Indigo Garners $56,000,000 Series B Financing Round 02/18/16 Boston
CRISPR Hits Wall Street as Editas Bags $94M in IPO 02/02/16 Boston
Early Bird Special Ends Today for New York’s Life Science Disruptors 02/02/16 New York
Tarveda Therapeutics Garners $38,000,000 Series C Funding Round 01/27/16 Boston
Ex-Biogen Exec’s New Startup Gets $61M More For Exosome Drugs 01/26/16 Boston
Codiak BioSciences Receives $61,000,000 Series B Financing Round 01/26/16 Boston
NYC’s Disruptive Biotech Startups take the Stage on March 29 01/21/16 New York
With Second Eye Drug Flop, Eleven Heads Back to Drawing Board 01/19/16 Boston
Eyeing First Trials, Syros Brings in $40M and More Crossovers 01/13/16 Boston
Page 1 of 16 next page »